30% off. Use code SUMMERSALE30 at checkout for 30% off for 12 months on Plus, Pro and Premium subscriptions. Subscribe now
United States Biotechnology & Medical Research

Grace Therapeutics, Inc (GRCE)

Track

Stock chart
Ticker: GRCE Exchange: NAS
Preparing chart...
Download chart Copy chart image Copy link Share to X Share


Subscribe to get access to the transaction volume chart and in-chart transaction details
• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Activity signal Earnings
Top insiders
Trades
Kavuru, Vimal
Director of Issuer
1 purchase — total 1,250,001 USD
Buy 25 Sep 2023
Value US$805,562.76 | Price 304.11 | Shares 29,490
Buy 25 Sep 2023
Value US$4,985,886.38 | Price 207.80 | Shares 57,597
Buy 31 Aug 2023
Value US$781.05 | Price 2.05 | Shares 381
Buy 31 Aug 2023
Value US$781.05 | Price 2.05 | Shares 381
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
Notification date Transaction date B/S Transaction type Insider and/or position Nb. shares
Price
Value 		Number of shares Price Value Details
2023-09-28 2023-09-25 B Purchase
3.2
Kavuru, Vimal

Director of Issuer

Non-Executive Director
29,490 +34.1%
304.11
US$805,563 		29,490 +34.1% 304.11 US$805,563
2023-09-27 2023-09-25 B Purchase
3.2
Kavuru Vimal
Non-Executive Director Large shareholder
57,597 +47.9%
207.80
US$4,985,886 		57,597 +47.9% 207.80 US$4,985,886
2023-09-05 2023-08-31 B Purchase
3.7
Olds, Donald John

Director of Issuer

Non-Executive Director
29,536
351.87
US$4,227,358 		29,536 351.87 US$4,227,358
2023-09-05 2023-08-31 B Purchase
3.0
Olds Donald
Non-Executive Director
381 +inf%
2.05
US$781 		381 +inf% 2.05 US$781
Explore more

More insider trading research around Grace Therapeutics, Inc

More insider trades in United States
Similar Healthcare companies with insider activity
More Pharmaceuticals & Medical Research companies with insider activity
More Biotechnology & Medical Research companies with insider activity
Insider trading in North America